HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Bristol-Myers Squibb

This article was originally published in The Rose Sheet

Executive Summary

Bristol-Myers Squibb: Reorganizes advertising agency responsibilities in an effort to "realign...brands and key categories by agency" and to provide for "marketing efficiencies," BMS said. Manhattan-based WRG-BDDP has been assigned the Clairol Natural Instincts line in the U.S. and Clairol brands in Europe. The Natural Instinct account was previously handled by J. Walter Thompson's New York office, which will still handle the majority of U.S. Clairol accounts. Bozell in New York will take on responsibility for the Excedrin PM and Ban accounts, which were previously held by J. Walter Thompson and Gotham's New York offices, respectively...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS002689

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel